Right Remedies - Stool Softener Docusate Sodium 100 Mg
NDC Package 70692-896-87

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Right Remedies - Stool Softener Docusate Sodium 100 Mg is a . Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-896 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
70692-896-87
Package Description
7 CAPSULE, LIQUID FILLED in 1 BOTTLE
Product Code
70692-896
11-Digit Billing Format
70692089687

Clinical Specifications

Proprietary Name
Right Remedies - Stool Softener Docusate Sodium 100 Mg
Dosage Form
-

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc.
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-02-2026
End Marketing Date
09-02-2026
Listing Expiration
09-02-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-896-87 identifies a specific commercial package of 7 capsule, liquid filled in 1 bottle of Right Remedies - Stool Softener Docusate Sodium 100 Mg, labeled by Strive Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strive Pharmaceuticals Inc. on September 02, 2026. The current certification is valid through September 02, 2026.

How is this Strive Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692089687. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-896-87
11-Digit CMS (5-4-2)
70692-0896-87

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.